Morning Market Losers

Regado Biosciences RGDO dropped 57.10% to $2.90 following the announcement of halt of patient enrollment in REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform. NQ Mobile NQ shares slipped 29.59% to $4.76 after the company announced certain changes to its Board of Directors and provided a status update on its 2013 annual audit. Tekmira Pharmaceuticals TKMR tumbled 14.23% to $11.81 after the company received notice of clinical hold for TKM-Ebola Phase I clinical trial from the FDA. BIND Therapeutics BIND shares declined 9.16% to $11.70 after the company reported the closing of collaboration deal with Amgen AMGN. Real Goods Solar RGSE fell 8.39% to $2.66 as the company priced 2.92 million units at $2.40 per unit. SYNNEX SNX dipped 4.13% to $70.88 after the company issued a downbeat outlook for the third quarter. It expected adjusted earnings of $1.45 to $1.50 per share on revenue of $3.3 billion to $3.4 billion. Analysts were projecting earnings of $1.53 per share on revenue of $3.29 billion.